RSI breakout - 20ma brake above - 17p / 23.6p targetsvolume spike today on no news, looking rather strong if close above 20ma this week.
looks like it's breaking the down trend.
17p 1st target
23.6p 2nd target area
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.03EUR
−50.12 MEUR
69.34 MEUR
159.68 M
About ALLERGY THERAPEUTICS ORD GBP0.001
Sector
CEO
Manuel Llobet
Headquarters
Worthing
Website
Employees (FY)
612
Founded
2004
ISIN
GB00B02LCQ05
Allergy Therapeutics Plc is a biotechnology company, which engages in the Research and Development of allergy treatments. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HHU is 0.04 EUR — it hasn't changed in the past 24 hours. Watch ALLERGY THERAPEUTICS PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ALLERGY THERAPEUTICS PLC stocks are traded under the ticker HHU.
HHU stock has risen by 2.38% compared to the previous week, the month change is a 34.37% rise, over the last year ALLERGY THERAPEUTICS PLC has showed a 34.37% increase.
HHU stock is 0% volatile and has beta coefficient of 1.72. Track ALLERGY THERAPEUTICS PLC stock price on the chart and check out the list of the most volatile stocks — is ALLERGY THERAPEUTICS PLC there?
Today ALLERGY THERAPEUTICS PLC has the market capitalization of 184.80 M, it has increased by 9.19% over the last week.
Yes, you can track ALLERGY THERAPEUTICS PLC financials in yearly and quarterly reports right on TradingView.
ALLERGY THERAPEUTICS PLC is going to release the next earnings report on Sep 25, 2024. Keep track of upcoming events with our Earnings Calendar.
ALLERGY THERAPEUTICS PLC revenue for the last quarter amounts to 38.72 M EUR despite the estimated figure of 38.75 M EUR. In the next quarter revenue is expected to reach 32.90 M EUR.
HHU net income for the last quarter is −18.05 M EUR, while the quarter before that showed −40.22 M EUR of net income which accounts for 55.12% change. Track more ALLERGY THERAPEUTICS PLC financial stats to get the full picture.
No, HHU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2024, the company has 612.00 employees. See our rating of the largest employees — is ALLERGY THERAPEUTICS PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLERGY THERAPEUTICS PLC EBITDA is −41.45 M EUR, and current EBITDA margin is −51.40%. See more stats in ALLERGY THERAPEUTICS PLC financial statements.
Like other stocks, HHU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLERGY THERAPEUTICS PLC stock right from TradingView charts — choose your broker and connect to your account.